Our results clearly underscore the critical role played by the cancer cell-associated mPGES-1 in the supply of elevated levels of PGE2, which, in turn, in a paracrine/autocrine fashion, control the EGF/EGFR-mediated tumorigenicity and angiogenesis. The gene discussed is EGFR; the disease is cancer.